Howard P. Milstein
Howard P. Milstein is Chairman, President and Chief Executive Officer of New York Private Bank & Trust and its operating bank, Emigrant Bank (the country’s largest privately owned, family-run bank). He also chairs and operates the Milstein family’s real estate companies, including Milstein Properties, Milford Management and MB Real Estate. Howard is founding Chairman of the merchant bank FriedbergMilstein. In 2007, Howard acquired, through Emigrant Bank, a full partnership interest in the Nicklaus Companies, LLC, and Co-Chairs the global business with the legendary professional golfer Jack Nicklaus.
Howard’s broad interests are manifest in numerous successful entrepreneurial businesses across a range of sectors, including: real estate, consumer goods, energy, entertainment, sports, financial services, technology, and insurance. He is considered a thought leader on business, the economy, infrastructure, philanthropy and entrepreneurship.
Howard provides significant, hands-on leadership and commitment to a range of communal, educational and civic organizations through his own philanthropic organization, the Howard and Abby Milstein Foundation. He is particularly active in the fields of medical research and healthcare delivery and also dedicates time and significant support to international affairs, higher education, disaster relief, the arts and communal giving.
Milstein Family Connection to China
The Milstein family has an enduring connection to China and the Chinese people. Howard Milstein’s father, Paul Milstein, was active in China at the very beginning of China’s opening to the West.
Howard made his first trip to China with his wife in 1980, visiting Hong Kong, Shanghai, and Beijing. More recently, Howard’s business interests in China have been in the financial and technology sectors and will continue to grow in the coming years. Notably, Howard is involved with ResoursePro, an insurance business with more than 1,000 employees in Qingdao & Jinan.
In 2011, the Milstein Medical Asian American Partnership Foundation (MMAAP Foundation) was created by Howard and Abby Milstein and the Paul Milstein Family, to contribute to world health by developing mutually beneficial partnerships between the United States and China, as well as greater Asia. Howard conceived of the MMAAP Foundation after meeting with the Chinese Ministry of Health to facilitate interactions between his medical philanthropic interests in the United States and leading Chinese efforts in clinical care and medical research. In December 2011, the MMAAP Foundation framework was presented to Vice Minister, Liu Qian, MD of the Ministry of Health of the People’s Republic of China.
The MMAAP Foundation provides funding to Geriatric Medicine, Dermatology, Hematology, Translational Medicine and Reproductive Medicine, in the form of Fellowship Awards and Research Project Awards, which aim to support medical researchers who have the potential to affect healthcare in China. MMAAPF partners with more than twenty prestigious institutions in China, including Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and West China Hospital.
In October 2014, the MMAAP Foundation hosted a successful bilateral Sino-US Symposium at the Peking Union Medical College Hospital, Beijing, China. The Symposium was an opportunity for the Chairperson from each of five expert panels in the fields of geriatrics, dermatology, hematology, translational medicine and reproductive medicine to present their findings. The Symposium was attended by Liu Quian, MD, Vice Minister of the National Health and Family Planning Commission and Cao Xuetao, MD PhD, President of the Chinese Academy of Medical Sciences and member of the Chinese Academy of Engineering. Howard Milstein held meetings with the Vice Minister and President and the MMAAP Foundation was able to secure their further support for coming initiatives.
In May 2015, Howard was elected to the Board of Directors of the National Committee on U.S.-China Relations. In March 2016, the China Association for International Exchange of Personnel announced that Howard will receive the prestigious Marco Polo Award, the highest honor given to a non-Chinese citizen.
Additional Medical Research & Philanthropy
Howard serves as the Chairman of the Board of New York Blood Center, which supplies blood to more than 20 million people in the New York area and, in 2007, established the Howard P. Milstein National Cord Blood Center, the world’s largest public cord blood bank. In 2014, the National Cord Blood Center was awarded the prestigious “Best Biotechnology Product” by Prix Galien USA for HEMACORD – the first FDA-licensed hematopoietic stem cell product. The Prix Galien Award is considered the biomedical industry’s highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices.
In addition, Howard is Chairman of the American Skin Association and the Howard and Georgeanna Jones Foundation for Reproductive Medicine. He also serves on the Board of the Nicklaus Children’s Health Care Foundation.
Howard is on the Board of the Weill Cornell Medical College. He and his wife, Abby sponsored the Abby and Howard Milstein Core Facility and Program in Chemical Biology, which is focused on infectious diseases, including tuberculosis and malaria.
At Cornell University, Howard is Trustee and Presidential Counselor and Overseer, Cornell Medical College.
Leadership in Civic, Business and Higher Education
In 2011, Howard was selected by Governor Andrew M. Cuomo to serve as the Chairman of the New York State Thruway Authority. The New York State Senate unanimously confirmed Howard’s appointment in June 2011. Howard’s tenure as Chairman was arguably the most productive and successful in Thruway history. Howard received the Regional Plan Association’s Lifetime Achievement Award in 2013 to recognize his management of the procurement process for the replacement of the Tappan Zee Bridge, which saved taxpayers more than $2 billion over original estimates. In 2014, President Obama stated that the Tappan Zee replacement serves as a model for infrastructure projects nationwide.
Howard has served as a member of the Board of the Economic Club of New York and is a member of the Executive Committee of the Real Estate Board of New York. He is a member of the Real Estate Forum of the Columbia University Business School and the Real Estate Roundtable, and serves on the Columbia M.B.A. Real Estate Program Advisory Board. He serves on the Executive Committee of the Dean’s Advisory Board of Harvard Law School. Howard serves on the Boards of the Shakespeare Theatre in Washington, D.C., and the National September 11 Memorial & Museum.
In 2008, Howard was honored as the Entrepreneur of the Year by Cornell University. In 2014-2015, Howard sponsored the “Milstein Symposia” with the Miller Center, including two seminal programs on entrepreneurship and next generation manufacturing.
In April 2014, Howard received the Insignia of Chevalier in France’s Legion of Honor, in recognition of his personal commitment to French-American cooperation and friendship, and fostering the French-American partnership in cultural and economic areas.
Other honors include recognition by New York Blood Center (NYBC) as the first individual inductee to NYBC’s Hall of Fame in November 2015 and by the United Hospital Fund with the Health Care Leadership Award in October 2015. In addition, Howard was recognized with the Community Builder Award from Phipps Houses, Humanitarian Award from the American Skin Association, JASA Man of the Year Award, Make a Wish Foundation Award, ORT Community Builder Award, Tanenbaum Center Corporate Bridge Builder Award, awards from the Jewish National Fund and B’nai B’rith Youth Services, the Catholic Youth Organization Gold Medal Award, Emerald Isle Immigration Society Robert Briscoe Award, Federal Law Enforcement Foundation Humanitarian Award, and Greater Harlem Chamber of Commerce Community Service Award. In March 2012, Howard was sworn in as an honorary FDNY Battalion Chief, in recognition of his significant support for the Fire Department and the people of New York.
A graduate of Cornell University, Howard earned a B.A. in Economics summa cum laude (1973). At Harvard University, he earned both his Law and Business degrees in the JD/MBA Program (1977). He was admitted to the New York State Bar, and is a member of the Federal Bar Council and the American, New York State and New York City Bar Associations.
Howard is the elder son of Irma Milstein and the legendary businessman and philanthropist Paul Milstein. Howard is married to Abby Sniderman Milstein and they have a son, Michael.
Sean X. Leng, MD, PhD
Sean Xiao Leng, MD PhD is an Associate Professor of Medicine and board-certified geriatrician in the Division of Geriatric Medicine and Gerontology at Johns Hopkins University School of Medicine. Dr. Leng was born in China and had his initial medical training at Jiangxi Medical College, Peking Union Medical College (PUMC) Hospital, and Chinese Academy of Medical Sciences (CAMS). He emigrated to the United States in 1989 and obtained a PhD at Texas A&M University, a research fellowship at Yale University, and further clinical training including geriatrics fellowship at Johns Hopkins University. In collaboration with the PUMC Hospital, Dr. Leng has led Hopkins’ effort on geriatrics program development in China since 2006. He was among the first to establish a model for international geriatrics collaboration between the US and China with an emphasis on high quality training of geriatrics multidisciplinary workforce, a critical step for improving care for the largest aging population in the world. This pioneering work, funded by the China Medical Board, was published by the Journal of the American Geriatrics Society (JAGS). To promote geriatrics principles and disseminate innovative care models to China, Dr. Leng has served as the guest editor and developed a special geriatrics series published by China Medical Tribune, a medical newspaper reaching out to two million physicians in China. Since 2011, he has co-organized the annual PUMC – Hopkins national geriatrics conference at PUMC Hospital, Beijing, China. He has also played an important role in organizing the annual Chinese Congress of Gerontology and Health Industry (CCGI) conference and leading the effort editing a dedicated JAGS supplement issue each year publishing meritorious scientific abstracts presented at the conference. Dr. Leng has served as Special International Expert Adviser for the Chinese Geriatrics Society, Chinese Medical Association. In 2014, he served as one of the two teaching professors for the first Advanced Training Course in Geriatric Medicine (ATCGM) organized by the Chinese Geriatrics Society and Ministry of Health. Through these and other efforts, Dr. Leng has established high level collaborative relationships with the Ministry of Health, the Chinese Geriatrics Society, PUMC, CAMS, and other major medical and governmental institutions in China. With his training in both the US and Chinese healthcare systems as well as ongoing collaborations, Dr. Leng has developed the unique skill sets and expertise in building the exchange and partnership of excellence in healthcare and biomedical research between the two countries as well as in promoting quality senior health for both countries.
Dr. Leng is also a physician scientist and Paul Beeson scholar in aging research (www.beeson.org). He directs translational aging research in his NIH-funded laboratory at Johns Hopkins, focusing on frailty, chronic cytomegalovirus infection, inflammation, and influenza immunization in older adults. Current research funding includes NIH R01, R21, and Center of Excellence for Influenza Research and Surveillance (CEIRS). He has published over 70 scientific papers. Dr. Leng also serves on the editorial board of JAGS, Journals of Gerontology: Medical Sciences and National Scientific Advisory Council of the American Federation for Aging Research. He was named the Executive Vice President of the Milstein Medical Asian American Partnership (MMAAP) Foundation and Director of the Irma and Paul Milstein Program for Senior Health in 2011, its Vice Chair and Chief Operating Officer in 2012, and President in 2014.
Gerald Lazarus, MD
Dr. Lazarus graduated with distinction from the George Washington University School of Medicine, followed by internal medicine training at the University of Michigan. After spending 3 years at the National Institutes of Health doing connective tissue research, he entered a Dermatology residency at the Massachusetts General Hospital where he became Chief Resident in Dermatology at Harvard. Lazarus was then awarded a fellowship to the Strangeways Laboratories at Cambridge University in England. Upon returning to the United States, he became Chief of Dermatology at Montefiore and Professor of Dermatology at Albert Einstein and then moved to Duke University as Chief and Callaway Professor of Dermatology. He then became Chair of Dermatology and Hartzell Professor at the University of Pennsylvania (UPenn) in 1982. During his time at Pennsylvania, he was awarded a John Simon Guggenheim Fellowship to the University of Geneva as well as the Lindback award as one of the outstanding teachers in the School of Medicine. During his time at UPenn, the Department became the leading recipient of NIH support in Dermatology. In 1993, he became Dean of the Medical School and CEO of the Medical System at the University of California Davis. In 1999, under the auspices of the China Medical Board, he moved to Beijing, China with his wife Audrey Jakubowski Lazarus, PhD, as advisers to the President of Peking Union Medical College/ Chinese Academy of Medical Sciences and the Ministry of Health. During their 3 years living in Beijing, they worked on: United States reform, United States management, evidence based medicine, patient satisfaction and quality of care. They lectured extensively to medical students, faculty and national medical meetings and traveled extensively to key Chinese medical schools, business schools and United States institutions. They published a series of papers in both Chinese and American literature including an article in the Washington Post. In 2002, he returned to the United States where he currently serves as Professor of Dermatology and Medicine and Founder of the Johns Hopkins Wound Center. At Hopkins, he continued participating in the development of joint programs between China and the United States in Nursing Education and Geriatrics.
Dr. Lazarus has published over 400 articles, 7 books, and has been President of the Society of Investigative Dermatology and a board member of the American Academy of Dermatology. He has received the Montagna Award of the Society of Investigative Dermatology and Sultzberger award of the American Academy of Dermatology. He currently serves as a member of the Combat Wound Initiative Scientific Advisory Board. He is a member of the American Society for Clinical Investigation, the Association of American Physicians and is a Fellow of the American College of Physicians and the American Academy of Dermatology. He has been awarded the Distinguished Alumnus Award of The George Washington University where he now serves as a member of the University’s Board of Trustees.
Advisory Board Member
Mr. Charles Wang is the President of Milstein China, the entity responsible for the oversight of all Milstein activities in Greater China.
Mr. Wang joined Oaktree Capital in 2007 and served as Managing Director, responsible for Oaktree’s business in Greater China. Prior to Oaktree, Mr. Wang was a Principal and founding partner at Pangaea Capital, where he was responsible for marketing and capital management. From 2001 until 2006, Mr. Wang served as a Senior Investment Officer at the New York State Common Retirement Fund, the 2nd largest public pension fund in the U.S. From 1998 to 2001, Mr. Wang was a Director at Clemente Capital, responsible for the China region. Mr. Wang has over 20 years of experience in the China related investment business and over that period has developed good relationships with major Chinese institution and entrepreneurs.
Since 2008, Mr. Wang has been advising Chinese institutional investors to invest in the U.S Real Estate and other opportunities, and also served as an advisor to some Chinese Banks and financial institutions.
Advisory Board Member
Peter Reisman is a co-founder, together with Andrew Farkas, and the CEO of C-Bridge Capital Partners. He has advised extensively on cross-border investments, as well as bilateral trade negotiations between the United States and China and Israel.
Mr. Reisman’s expertise in China dates back 24 years, when he became the first American to graduate with a Masters in Law from Peking University Law School. He later went on to obtain a Juris Doctor degree and LL.M. from Columbia Law School. After working in the Securities Group at Cravath, Swaine, & Moore LLP (both in New York and in Hong Kong), Mr. Reisman spent six years in the Israel Defense Forces as an officer in both a legal and advisory capacity, completing his service as the Director for the Asia Pacific Desk. He subsequently joined Island Capital Group as Senior Vice President in the capital markets group and is now using his extensive personal network and experience, and dividing his time, in advising Chinese, American and Israeli clients on cross-border investment opportunities. Mr. Reisman is fluent in Mandarin and Hebrew and serves as a member of the National Board of the Friends of the IDF, the advisory board for the Milstein Medical American Asian Partnership Foundation (MMAAPF), the National Committee on U.S. – China Relations, the advisory board for AJC’s Asia Pacific Institute and an Associate Member of the China General Chamber of Commerce-U.S.A.
Stephen A. Orlins
Advisory Board Member
Steve Orlins has been president of the National Committee on U.S. – China Relations since 2005. Prior to that, he was the managing director of Carlyle Asia and the chairman of the board of Taiwan Broadband Communications, one of Taiwan’s largest cable television and high speed internet providers. Prior to joining Carlyle, Mr. Orlins was a senior advisor to AEA Investors Inc., a New York based leveraged buyout firm, with responsibility for AEA’s business activities throughout Asia.
From 1983 to 1991, Mr. Orlins was with the investment banking firm of Lehman Brothers where he was a Managing Director from 1985 to 1991. From 1987 to 1990, he served as President of Lehman Brothers Asia. Based in Hong Kong, he supervised over 150 professionals with offices in Hong Kong, Korea, China, Taiwan, Thailand, Manila and Singapore. Prior to joining Lehman Brothers, Mr. Orlins practiced law with Coudert Brothers and Paul, Weiss, Rifkind, Wharton & Garrison in New York, Hong Kong and Beijing.
From 1976 to 1979, Mr. Orlins served in the Office of the Legal Advisor of the United States Department of State, first in the Office of the Assistant Legal Advisor for Political-Military Affairs and then for East Asian and Pacific Affairs. While in that office, he was a member of the legal team that helped establish diplomatic relations with the People’s Republic of China.
Mr. Orlins is a magna cum laude graduate of Harvard College and earned his law degree at Harvard Law School. He speaks Mandarin Chinese and is a member of the Council on Foreign Relations.
In 1992, Mr. Orlins was the Democratic nominee for the United States Congress in New York’s Third Congressional District.